Trial intelligence / Profile preview

NOBLE: Norspan in Korean Patients With Spinal Disorders

NCT01818700Phase 4Completed

Sponsor
Mundipharma
Start
Sep 2012
Primary completion
Jun 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of Norspan in spinal disorder, sponsored by Mundipharma. Started Sep 2012; status: completed.

02

Drugs

Norspan
03

Conditions

spinal disorder

Beyond the preview

Go deeper on NCT01818700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01818700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call